Standout Papers

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcome... 2019 2026 2021 2023 532
  1. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial (2019)
    Anders Widmark, Adalsteinn Gunnlaugsson et al. The Lancet

Immediate Impact

6 from Science/Nature 52 standout
Sub-graph 1 of 22

Citing Papers

Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
3 intermediate papers

Works of Björn Zackrisson being referenced

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
2019 Standout
Selective urological evaluation in men with febrile urinary tract infection
2001
and 3 more

Author Peers

Author Last Decade Papers Cites
Björn Zackrisson 1703 1297 921 91 2.8k
T. Rancati 2014 1611 1271 157 3.2k
Bernard Dubray 1594 1088 1383 115 3.0k
S. Gulliford 1131 873 775 85 1.9k
Teruki Teshima 1603 1065 846 196 2.8k
M. Wannenmacher 1432 933 901 150 3.2k
Takeshi Nishioka 1486 1597 1508 105 3.3k
N. Di Muzio 2211 1485 1183 137 3.2k
Kwan Ho Cho 1294 927 722 99 2.5k
P. Pommier 2025 1222 667 186 3.2k
Michael McLean 1752 867 422 100 3.4k

All Works

Loading papers...

Rankless by CCL
2026